0.1c cash backing and 0.2c NTA according to the last quaterly report. So we are sitting pretty much on it now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025